Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salomon Manier

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
Exosomes in Tumor AngiogenesisKarma Z Salem, Michele Moschetta, Antonio Sacco, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
microRNA aberrations in Waldenström macroglobulinemiaAntonio Sacco, Yong Zhang, Patricia Maiso, et al.
Nature Reviews. Disease Primers|June 27, 2024
Multiple myelomaFlorent Malard, Paola Neri, Nizar J Bahlis, et al.
Cancer Treatment and Research|October 4, 2016
Epigenetics in Multiple MyelomaSiobhan V Glavey, Salomon Manier, Antonio Sacco, et al.
Clinical Hematology International|April 15, 2023
Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)Nizar J Bahlis, Luciano J Costa, Thierry Facon, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Immunological Reviews|December 17, 2014
Targeting the bone marrow microenvironment in multiple myelomaYawara Kawano, Michele Moschetta, Salomon Manier, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial SubanalysisSalomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemiaStéphanie Poulain, Charles Herbaux, Elisabeth Bertrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom MacroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Methods in Molecular Biology (Clifton, N.J.)|November 19, 2016
Exosomes in Tumor AngiogenesisKarma Z Salem, Michele Moschetta, Antonio Sacco, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
microRNA aberrations in Waldenström macroglobulinemiaAntonio Sacco, Yong Zhang, Patricia Maiso, et al.
Nature Reviews. Disease Primers|June 27, 2024
Multiple myelomaFlorent Malard, Paola Neri, Nizar J Bahlis, et al.
Cancer Treatment and Research|October 4, 2016
Epigenetics in Multiple MyelomaSiobhan V Glavey, Salomon Manier, Antonio Sacco, et al.
Clinical Hematology International|April 15, 2023
Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)Nizar J Bahlis, Luciano J Costa, Thierry Facon, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Immunological Reviews|December 17, 2014
Targeting the bone marrow microenvironment in multiple myelomaYawara Kawano, Michele Moschetta, Salomon Manier, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 1, 2023
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial SubanalysisSalomon Manier, Meletios Dimopoulos, Cyrille Hulin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemiaStéphanie Poulain, Charles Herbaux, Elisabeth Bertrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom MacroglobulinemiaAldo M Roccaro, Antonio Sacco, Xiaojing Jia, et al.
Pageof 16